Atlas Trials

Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects

Clinical trial NCT02739373 · COMPLETED

Trial details

NCT number
NCT02739373
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Severe Sepsis
Start date
2016-04-18
Primary completion
2016-12-14
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.